FDA Adverse Event Injury Summary report: N

EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE

MDR report key: 5148575 · Received October 14, 2015

Report

Report Number
2015691-2015-02736
Event Type
Injury
Date Received
October 14, 2015
Date of Event
September 18, 2015
Report Date
September 18, 2015
Manufacturer
EDWARDS LIFESCIENCES
Product Code
NPT
PMA / PMN Number
P130009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). INVESTIGATION IS ONGOING.

Description of Event or Problem · 1

AS REPORTED, 15 DAYS POST DEPLOYMENT OF A 26MM SAPIEN XT VALVE THE PATIENT WAS READMITTED TO THE HOSPITAL WITH CHF. DURING THE ADMISSION AN ECHO REVEALED THE PATIENT HAD SEVERE AORTIC INSUFFICIENCY. A BAV WAS PERFORMED WITH A 25MM BALLOON. NO REDUCTION IN AI WAS NOTED. THE DECISION WAS THEN MADE TO DEPLOY A SECOND VALVE. A SECOND 26MM SAPIEN S3 WAS IMPLANTED LEAVING WITH THE PATIENT WITH NONE/TRACE AI VIA ECHO AND ANGIOGRAPHY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
679894 EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT EDWARDS LIFESCIENCES 9300TFX26

Patients

Seq Age Sex Outcome Treatment
1 75 YR Required Intervention